who invented glp 1 drugs Reflections on the discovery GLP-1 as a satiety hormone: Implications for obesity therapy and future directions GLP-1 Drug Side Effects May

Henry Sobo

This leads to the build-up of lipid intermediates such as long-chain acyl-CoAs, acylcarnitines, ceramides, diacylglycerols, and triacylglycerols within cardiomyocytes (52)

This, however, does not apply to other GLP-1RAs approved for the treatment of T2DM, including the same liraglutide (Victoza) and semaglutide (Ozempic or Rybelsus) at lower dosages, prompting several stakeholders to request an updated guidance 232 and more caution in media enthusiasm 233

You should consult a healthcare provider if you are unsure about your current dose escalation step, experiencing persistent side effects, transitioning between different semaglutide products, combining semaglutide with other peptide stacks , or have underlying conditions that might affect how you metabolize the medication

All patients were then followed from the index date for up to 12 months, or until the occurrence of an outcome, death, or censoring, whichever came first